Does Magnesium Threonate Cross the Blood-Brain Barrier: What Studies Show
Magnesium L-threonate is often described as a form that "crosses the blood-brain barrier" and therefore supposedly delivers magnesium directly to the brain. The scientific evidence is more complicated: in animal studies, magnesium levels in the central nervous system have been altered after administration of this compound, and L-threonate has been detected in cerebrospinal fluid. However, this is not the same as evidence that the salt molecule can cross the barrier unchanged in humans.
To properly understand the results, three questions need to be separated: what gets into the central nervous system, how is it measured, and whether the conclusion from animals or cells can be transferred to humans.
Why the blood-brain barrier issue is important
The blood-brain barrier (BBB) is a system of tightly connected cells in the brain's blood vessels that controls the exchange between blood and nervous tissue. The barrier is not an impermeable wall: water, nutrients, and ions can enter through regulated mechanisms. Therefore, the question "does magnesium threonate cross the BBB" needs to be clarified: is it the transport of magnesium ions, L-threonate, or the entire salt molecule?
Magnesium is needed by nerve cells for many processes, but the concentration of magnesium in blood plasma is not the same as the concentration in cerebrospinal fluid or inside a neuron. Even if a substance changes its level in the central nervous system after ingestion, this does not indicate the route by which it got there.

What the 2010 experiment by Slutsky and co-authors showed
Slutsky et al. (2010) gave rats magnesium L-threonate and observed increased brain magnesium levels, as well as changes in synaptic parameters and behavioral memory tests. This publication was an important basis for interest in the form of magnesium related to brain function.
But the rat study does not directly prove that in humans the entire magnesium + L-threonate complex crosses the BBB unchanged. Nor does it prove that any increase in magnesium in the blood will necessarily cause a corresponding increase in the brain.
L-threonate in cerebrospinal fluid: what was established in 2016
Sun et al. (2016) investigated the separate role of L-threonate. The authors reported its presence in the cerebrospinal fluid of rats and an increase in concentration after oral administration of the magnesium salt of L-threonate. This is strong evidence for the availability of threonate to the central nervous system in this experimental model.
In hippocampal neuron cultures, threonate increased intracellular Mg²⁺ concentrations and altered synaptic parameters. The effect was dependent on the function of the GLUT glucose transporters. An important distinction: the authors investigated GLUT-dependent processes in a cellular system, and did not demonstrate the transport of whole magnesium L-threonate across the human BBB by GLUT.
What the research actually proves — a brief comparison
| Research | What is installed | What this doesn't prove |
|---|---|---|
| Slutsky et al., 2010, rats | Increased brain magnesium and changes in synaptic and behavioral parameters | Transport of an entire molecule across the human BBB |
| Sun et al., 2016, rats and neuronal cultures | Threonate in cerebrospinal fluid; GLUT-dependent cellular changes | GLUT transport of unchanged salt across the human BBB |
| Lopresti and Smith, 2026, adults | Difference in some cognitive tests in 6 weeks | Direct measurement of magnesium in the brain or its pathway |
Is there any evidence of brain penetration in humans?
Human clinical trials have mainly assessed cognitive tests, sleep, or well-being, rather than the direct transfer of Mg²⁺ or threonate across the BBB. For example, Lopresti and Smith (2026) conducted a six-week randomized trial in which 100 adults aged 18–45 years received 2 g of magnesium L-threonate daily or placebo. Some cognitive measures differed between groups, while others did not. The study was funded by a company affiliated with the study formula.
These results are not a measure of blood-brain barrier permeability. Without direct measurements in the human central nervous system, it is not possible to determine whether the transfer of whole salt, its components, or indirect effects through physiological mechanisms occurred. Clinical effect and proof of transport route are different scientific questions.
Why can't we say that other forms of magnesium don't reach the brain?
Magnesium ions are a natural component of nervous tissue regardless of the dietary form from which they enter the body. Magnesium regulation in the central nervous system occurs continuously, not only after taking L-threonate. The statement that “only threonate crosses the BBB” does not follow from the experiments given.
A separate study by Romeo et al. (2019) examined the effects of different magnesium salts on transport and barrier permeability in laboratory cell models. Such models are helpful in studying magnesium transport, but by themselves do not provide a basis for ranking all available supplements in terms of their ability to penetrate the human brain.
The correct formulation as of today is as follows: for magnesium L-threonate, there is experimental data on changes in magnesium metabolism in the central nervous system of animals; direct transport of the intact molecule across the human BBB has not been conclusively established.

How to read BBB penetration claims on labels and in advertising
The words “increases magnesium in the brain,” “L-threonate is detectable in cerebrospinal fluid,” and “the entire molecule crosses the BBB” describe different claims. Each requires its own type of evidence. In particular, cell or animal studies do not automatically translate into clinical evidence in humans.
It is also worth considering the difference between the mass of salt and the mass of elemental magnesium: the value in grams on the label does not mean the same amount of Mg²⁺. This arithmetic does not indicate permeability through the BBB. If the question concerns taking a supplement, the guideline is the instructions for the specific product and individual circumstances, and not the interpretation of the laboratory mechanism as a ready-made recommendation.
Frequently asked questions
Does Magnesium L-Threonate cross the blood-brain barrier?
Animal studies have shown changes in magnesium and threonate in the central nervous system. There is no direct conclusive evidence that a whole molecule of magnesium L-threonate crosses the BBB in humans.
Has it been proven that threonate enters the cerebrospinal fluid?
In a study by Sun et al. (2016), L-threonate was detected in the cerebrospinal fluid of rats; its concentration increased after administration of the test compound. This is not a direct measurement in humans.
What does GLUT-dependent mechanism mean?
In cellular experiments, the effects of L-threonate on intracellular magnesium were dependent on GLUT glucose transporters. This does not prove that the whole salt is transported across the BBB.
Are there any studies on the penetration of magnesium L-threonate into the human brain?
Existing clinical studies mainly evaluate functional parameters. They do not establish a direct route of transport of the intact compound across the human BBB.
Can L-threonate alone provide magnesium to the brain?
No. Magnesium is naturally present in nervous tissue, and its intake and concentration are regulated by the body. The claim that only one salt is exclusive has not been proven.
Does a memory change mean that the compound has passed the BBB?
No. Behavioral and cognitive outcomes may be related to different mechanisms. Separate measurements are needed to demonstrate a specific pathway of transport.
Can the amount of magnesium on the label be used to estimate brain penetration?
No. Elemental magnesium content indicates the composition of a serving, but does not measure brain concentration or blood-brain barrier permeability.
Sources
- Slutsky I. et al. (2010). Enhancement of learning and memory by elevating brain magnesium. Neuron. PubMed
- Sun Q. et al. (2016). Regulation of structural and functional synapse density by L-threonate through modulation of intraneuronal magnesium concentration. Neuropharmacology. PubMed
- Shen Y. et al. (2019). Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson's Disease. Neuropsychiatric Disease and Treatment. PubMed
- Romeo V, Cazzaniga A, Maier JAM (2019). Magnesium and the blood-brain barrier in vitro: effects on permeability and magnesium transport. Magnesium Research. PubMed
- Lopresti AL, Smith SJ (2026). The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomized, double-blind, placebo-controlled trial. Frontiers in Nutrition. PubMed
Dietary supplement. Not a medicine. Consult a doctor before use.
Products related to this post
Related Posts
Comments
Sports nutrition manufacturer in Ukraine StarkPharm © 2026


